ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Litigation Blogs -> How Appealing

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Litigation

: How Appealing

En banc U.S. Court of Appeals for the Federal Circuit decides what constitutes a "new and useful process" for purposes of patent eligibility

ADVERTISEMENTS
En banc U.S. Court of Appeals for the Federal Circuit decides what constitutes a "new and useful process" for purposes of patent eligibility: You can access today's 132-page ruling in In re Bilski at this link. Twelve judges participated in the ruling. Nine joined in the majority opinion, while the three remaining judges each issued separate dissenting opinions. The case has been viewed as exceptionally important because it involves the patentability of business methods.

Joe Palazzolo of Legal Times covered the en banc oral argument in an article headlined "Judges Ask for More Concrete Patent Test; Federal Circuit argument over business method test answers few questions."

Full post as published by How Appealing on October 30, 2008 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Selection of State Supreme Court Judges
How State Court Judges are Selected

Law Enforcement and Criminal Justice Career Choices
Descriptions of law enforcement occupations

Privacy Protection Act 42 USC 21A
Federal Newsroom Law

How to Become a US Citizen
Citizenship Eligibility, Application, Exmaination

California Supreme Court Proposition 8 Decision
Court Rejects Challenges to Proposition 8, but Finds Marriages Valid

Federal Adoption Tax Credit
Financial Incentive for Adoptive Parents

Lawsuits and Settlements

Personal Injury
Appeals Court Upholds Congressional Legislation

Philip Morris
Jury Decides Against Big Tobacco

Specialty Lamp International
Recalls Counterfeit Circuit Breakers

Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.

Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.

DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.013 secs (new cache)